Table 4 Total treatment costs for with and without SEB scenarios in year 1
Patient type (CKD stage) | Treatment for anemia | Year 1 total costs ($) | |
|---|---|---|---|
Without SEB | With SEB | ||
Stage III/IV | Short acting ESA (SC) | 28,391,013 | 24,206,178 |
Long acting ESA (SC) | 29,532,964 | 25,179,805 | |
Epoetin SEB | - | 930,614 | |
Stage V | Short acting ESA (SC) | 23,648,751 | 20,162,925 |
Long acting ESA (SC) | 16,376,488 | 13,962,594 | |
Short acting ESA (IV) | 97,155,486 | 82,834,767 | |
Long acting ESA (IV) | 67,560,443 | 57,602,033 | |
Epoetin SEB | - | 3,193,963 | |
Total | 262,665,144 | 228,045,878 | |